OncoMatch/Clinical Trials/NCT06468254
An Exploratory Clinical Study of Statins for Improving Chemotherapy and Maintenance in Patients With Ovarian Cancer
Is NCT06468254 recruiting? Yes, currently enrolling (Jun 2026). This Phase 2 trial studies multiple treatments including Statin and Sugar pill for ovarian cancer.
Treatment: Statin · Sugar pill — This study aims to evaluate the effect of statins combined with conventional chemotherapy and maintenance therapy on the prognosis of ovarian cancer patients, exploring its potential to improve survival rates and quality of life.
Check if I qualifyExtracted eligibility criteria
Treatments studied
Other
Cancer type
Ovarian Cancer
Demographics
Lab requirements
Kidney function
Serum creatinine ≤1.5x ULN, or creatinine clearance rate ≥60 mL/min (Cockcroft-Gault formula)
Liver function
Total bilirubin ≤1.5x ULN or direct bilirubin ≤1.0x ULN; AST/ALT ≤2.5x ULN (≤5x ULN with liver metastases)
Liver Function: Total bilirubin ≤1.5x ULN or direct bilirubin ≤1.0x ULN; AST/ALT ≤2.5x ULN (≤5x ULN with liver metastases). Kidney Function: Serum creatinine ≤1.5x ULN, or creatinine clearance rate ≥60 mL/min (Cockcroft-Gault formula).
Structured fields extracted by AI. May contain errors — verify against the official protocol.
Frequently asked questions
Is NCT06468254 currently recruiting?
Yes, this trial is currently recruiting patients.
Is this trial open to male patients?
No. This trial enrolls female patients only.
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualifyRelated pages